Interestingly, HPS2 iPSC‐derived AECs recapitulated the disease phenotype, with altered surfactant secretion, and can therefore be instrumental for future studies aiming to discover new therapeutic agents for the treatment of HPS pulmonary fibrosis. The gene discussed is AP3B1; the disease is Hermansky-Pudlak syndrome.